MF - ELZONRISTM (tagraxofusp; SL-401) trials in MF look promising: https://ir.stemline…

Oct 9, 2018-edited

MF - ELZONRISTM (tagraxofusp; SL-401) trials in MF look promising:

Stemline Therapeutics Announces Positive Clinical Data from ELZONRISTM (tagraxofusp; SL-401) Trials in BPDCN, CMML and MF Delivered at the EHA…

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company…

ir.stemline.com

Comments

Momelotinib Granted FDA Fast Track Designation for Myelofibrosis

Momelotinib to begin clinical trial in individuals with Myelofibrosis

MedMaven

Sep 17

Idasanutlin Treatment for Polycythemia Vera and Essential Thrombocytopenia

Idasanutlin is active in the treatment of PV and ET and is currently being evaluated in a global phase 2 trial.

MedMaven

Jul 24

Long Term Survival in Myelofibrosis Improved with Early Use of Jakafi®

In addition to improving long term survival Jakafi® improves MF caused fatigue, spleenomegaly and kidney function.

Cancer Connect

Nov 26

Overview of Polycythemia Vera

Understand the symptoms, diagnosis, treatment & management of Polycythemia Vera.

Cancer Connect

Sep 13

Thalidomide - Jakafi Combo A Novel Approach for Treatment of Myelofibrosis

Thalidomide - Jakafi Combination may be Effective for Treatment of Myelofibrosis Associated Low Blood Counts

MedMaven

Feb 22

Daurismo Evaluated in Myelofibrosis

AML drug Daurismo evaluated in MF - further study warranted.

MedMaven

Apr 2

AVID200, a Novel TGF-beta 1 & 3 Inhibitor Begins Evaluation in Myelofibrosis

New study initiated to evaluate AVID in Myelofibrosis is underway.

MedMaven

May 7

International Marrow Donor Registries Reach 25 Million Potential Donors

International Marrow Donor Registries Reach 25 Million Potential Donors, Give Hope to Searching Blood Cancer Patients

Cancer Connect

Apr 1, 2015

MPN Research Foundation-PV Reporter-Cancer Connect Create Combined Community

Leading cancer centers create combined social community with MPNRF PV Reporter & Cancer Connect to support MPN patients

Cancer Connect

Apr 13

Jakafi Superior to Standard Therapy for Polycythemia Vera

Phase III Trial Finds Jakafi Superior to Standard Therapy for Polycythemia Vera

Cancer Connect

Apr 13

Cancer Connect

theRAconnection

Osteoporosis

The Spine Community

Women's Health